ABSTRACT Bone scintigraphy is a sensitive and popular method for imaging a wide array of benign or malignant skeletal abnormalities. However, the uptake of tracers used for bone scintigraphy may be observed in various extraosseous sites, thereby limiting its specificity. It is difficult to correctly localize such sites of uptake on planar bone scintigraphy alone. The addition of hybrid single-photon emission computed tomography-computed tomography (SPECT-CT) under such circumstances is very useful. The present essay illustrates the commonly encountered extraosseous uptake of T he ability to assess new bone formation makes bone scintigraphy a popular noninvasive diagnostic technique for imaging the skeletal system. Pathologic entities that commonly demonstrate increased uptake on bone scintigraphy are primary bone tumors, skeletal metastases, infections, and sites of skeletal trauma. Bone-seeking tracers such as 99m Tc-methylene diphosphonate (MDP) and its analogs localize to bone by chemisorption to the surface of hydroxyapatite crystals (1). Sites of new bone formation show increased uptake because of high regional perfusion and increased areas of proliferation. On occasion, certain abnormal processes involving soft tissues can also cause skeletal accumulation of radiotracer (extraosseous uptake) on bone scintigraphy apart from the physiologic excretion of tracer through the urinary tract (2). Probable mechanisms that have been proposed to explain extraosseous uptake of 99m Tc-MDP include a) increased regional vascularity and permeability; b) tumor necrosis with or without calcification; c) metastatic calcification in renal failure; d) increased tissue calcium concentration; e) serum hypocalcemia of any etiology; f) presence of collagen; and g) improper labeling of the radionuclide (3, 4). Knowledge regarding these potentially confusing entities is important because they may hinder correct interpretation of the disease in question. Identification of such nonosseous uptake becomes particularly difficult if planar scintigraphy is used alone. Additional use of hybrid single-photon emission computed tomography (SPECT)-computed tomography (CT) helps in proper anatomical localization of abnormal uptake noted on bone scintigraphy and improves the quality of interpretation. SPECT-CT increases the sensitivity of bone scintigraphy by detecting additional lesions, and the exclusion of sites of physiological tracer uptake also increases specificity. Attenuation and photon scatter correction of nuclear medicine images by hybrid imaging helps us to obtain more accurate image data. The functional significance of indeterminate bone lesions detected on anatomical imaging studies can also be characterized by SPECT-CT. This pictorial essay reviews a few examples of abnormal processes that may cause extraosseous uptake on bone scintigraphy encountered at our institute and highlights the significance of proper anatomical localization using SPECT-CT.
Tc-methylene diphosphonate (MDP) and the usefulness of hybrid SPECT-CT in clarifying 99m
Tc-MDP uptake.
T he ability to assess new bone formation makes bone scintigraphy a popular noninvasive diagnostic technique for imaging the skeletal system. Pathologic entities that commonly demonstrate increased uptake on bone scintigraphy are primary bone tumors, skeletal metastases, infections, and sites of skeletal trauma. Bone-seeking tracers such as 99m Tc-methylene diphosphonate (MDP) and its analogs localize to bone by chemisorption to the surface of hydroxyapatite crystals (1) . Sites of new bone formation show increased uptake because of high regional perfusion and increased areas of proliferation. On occasion, certain abnormal processes involving soft tissues can also cause skeletal accumulation of radiotracer (extraosseous uptake) on bone scintigraphy apart from the physiologic excretion of tracer through the urinary tract (2) . Probable mechanisms that have been proposed to explain extraosseous uptake of 99m Tc-MDP include a) increased regional vascularity and permeability; b) tumor necrosis with or without calcification; c) metastatic calcification in renal failure; d) increased tissue calcium concentration; e) serum hypocalcemia of any etiology; f) presence of collagen; and g) improper labeling of the radionuclide (3, 4) . Knowledge regarding these potentially confusing entities is important because they may hinder correct interpretation of the disease in question. Identification of such nonosseous uptake becomes particularly difficult if planar scintigraphy is used alone. Additional use of hybrid single-photon emission computed tomography (SPECT)-computed tomography (CT) helps in proper anatomical localization of abnormal uptake noted on bone scintigraphy and improves the quality of interpretation. SPECT-CT increases the sensitivity of bone scintigraphy by detecting additional lesions, and the exclusion of sites of physiological tracer uptake also increases specificity. Attenuation and photon scatter correction of nuclear medicine images by hybrid imaging helps us to obtain more accurate image data. The functional significance of indeterminate bone lesions detected on anatomical imaging studies can also be characterized by SPECT-CT. This pictorial essay reviews a few examples of abnormal processes that may cause extraosseous uptake on bone scintigraphy encountered at our institute and highlights the significance of proper anatomical localization using SPECT-CT.
Extraosseous uptake in neoplastic diseases

Metastatic disease
Metastatic diseases such as malignant pleural and pericardial effusion, hepatic metastases, and calcific metastases of osteosarcoma accumulate 99m Tc-MDP (2). Cellular necrosis due to ischemia or fat necrosis due to enzymatic action leads to deposition of calcium. Under normocalcemic conditions, deposition of calcium occurs in necrotic tissue and is called dystrophic calcification (5) . Tissue damage at times leads to collagen degeneration and is associated with calcium deposition. This mechanism operates when locoregional lymph nodes involved in the primary neoplastic disease becomes enlarged and accumulate calcium after necrosis. Fig. 1 shows such a case in a patient with prostate carcinoma who was referred for metastatic work-up. SPECT-CT images showed Tc-MDP accumulation in the enlarged left inguinal lymph node along with other metastatic sites. In the above case, SPECT-CT helped us to delineate the lymph node that, on planar imaging, was thought to be one of the metastatic skeletal deposits.
The liver is a common and frequent extraosseous site for metastatic deposits that sometimes also accumulate 99m Tc-MDP. Because the liver is extensively vascular and its high blood flow and dual blood supply make it the most frequent site of metastases, metastatic deposits are observed as focal areas of increased activity in the right lower hemithorax, usually due to carcinoma of the breast and lung, and adenocarcinoma of the gastrointestinal tract. The accumulation of 99m Tc-MDP is favored by regional blood flow variations, necrosis, and calcification in liver metastasis (6, 7) (Fig. 2) .
Certain metastatic tissues are metabolically similar to bone and also have the property of concentrating 99m Tc-MDP. The osteoid matrix produced by metastases from osteogenic sarcoma is one of the mechanisms by which extraosseous metastases from osteosarcomas concentrate Tc-MDP (8) . Fig. 3 shows an extraosseous metastatic deposit in the vastus lateralis muscle in the right thigh in an operated osteosarcoma of the right distal femur. SPECT-CT improved the clinical significance of this case by revealing extraosseous metastasis that was initially thought Tc-MDP-concentrating osteogenic metastases in the right lung field in another patient with osteosarcoma.
After intravascular injection, in addition to osseous uptake and renal excretion, 99m Tc-MDP rapidly distributes into the extracellular compartment. Malignant pleural effusions and peritoneal ascites occasionally are associated with uptake of 99m Tc-MDP and can be identified on bone scintigraphy by a diffuse increase in radiotracer uptake in the hemithorax, indicating malignant pleural effusion, a dangerous sign in patients screened for skeletal metastases (9) . Involvement of the pleural or peritoneal lining by neoplastic cells alters the capillary permeability through direct serosal involvement or lymphatic obstruction. This is increased in malignant effusions, which permit rapid diffusion of the radiopharmaceutical into the effusion, and because the blood concentration of the radiopharmaceutical is high, this diffusion easily occurs (8) . Fig. 5 shows a case of breast carcinoma with a diffuse increase in tracer uptake in the left hemithorax due to malignant pleural effusion. Although suspected on planar images, it was confirmed with SPECT-CT.
Primary tumors
Primary neoplasms, both benign and malignant, such as carcinomas of the breast and colon, as well as neuroblastoma and lymphoma, sometimes accumulate 99m Tc-MDP (2). In a normal postpubertal population, nonspecific symmetric uptake occurs in both breasts (10) . Uptake of 99m Tc-MDP in primary breast carcinoma is also common. Fig. 6 shows a focal area of radiotracer accumulation in the right anterior chest wall on planar images that corresponds to the breast lesion with calcification on SPECT-CT imaging. The exact mechanism of such uptake of radiotracer is still uncertain, and various factors have been proposed. Histological evidence of calcium deposition has been proposed to be the Tc-MDP uptake (11) . Adenocarcinomas of the lung, breast, or gastrointestinal tract with a mucinous component possess a glycoprotein that is similar to ossifying cartilage biochemically and binds calcium salts; in turn, this glycoprotein also accumulates 99m Tc-MDP (8).
Extraosseous uptake due to metabolic causes
Metabolic causes such as serum hypercalcemia of any cause, such as renal failure, hepatocellular disease, sarcoidosis, sickle cell anemia, thalassemia, gout, or amyloidosis (2), if present, concentrates 99m Tc-MDP and provide indirect evidence of the pathology. Serum calcium, phosphorus, and magnesium are within normal limits and are kept regulated under the influence of parathyroid hormone. Disturbances of calcium metabolism, particularly in hyperparathyroidism, lead to metastatic calcification, which refers to calcium deposition in tissues subjected to hypercalcemia. Metastatic calcification may be observed with increased secretion of parathyroid hormone, increased resorption of bone, vitamin D-related disorders, and renal osteodystrophy leading to secondary hyperparathyroidism (5). Alkaline environments in tissues favor calcium and phosphorus deposition in areas of metastatic calcification. Serum hypercalcemia leads to 99m Tc-MDP accumulation in tissues with a high-alkaline environment such as alveolar walls of lungs, tubules of kidneys, and gastric mucosa. Tumor-induced hypercalcemia and metastatic calcification are common. Secretion of systemically or locally active humoral mediators is responsible for the associated bone destruction and consequent severe hypercalcemia (12) . Tumor-induced metastatic calcification may involve multiple organs. Fig. 7 shows a case of breast carcinoma presenting with hypercalcemia and diffusely increased radiotracer uptake in bilateral lung fields and the stomach (best appreciated on SPECT-CT images) Tc-MDP. The hydroureteronephrosis causes tracer accumulation in the pelvicalyceal system, whereas interstitial diseases cause symmetrical retention of radiotracer in the kidneys. Ectopic or malpositioned kidneys also become an unusual cause of extraosseous uptake during bone scintigraphy (13) . Renal or ureteric calculi comprising calcium oxalate crystals also sometimes causes adsorption of 99m Tc-MDP onto the surface of calcium salts. Ureteric calculi can be observed as a focal area of increased radiotracer uptake, and when it is in the region of the pelvic ureter, it may be confused with skeletal metastases in patients referred for metastatic work up. SPECT-CT is extremely useful in such cases, as shown in Fig. 8 .
Extraosseous uptake due to trauma
Traumatic causes such as myositis ossificans, muscle necrosis, contusion, hematoma, and surgical and intramuscular injection sites show increased uptake of 99m Tc-MDP. Myositis ossificans occurs after trauma due to reactive new bone formation at the traumatic site. The fibroblasts present in the lesion recruit proliferating osteoblasts, leading to the formation of new woven bone that shows avid 99m Tc-MDP uptake. Long-standing, matured lesions show heterotopic ossification in the skeletal muscle on CT but are less avid for 99m Tc-MDP uptake (14) . The 99m Tc-MDP uptake also occurs in muscles around joints in cases of paraplegia because of the loss of sensation and unperceived repeated trauma (Fig. 9) (13) .
Other causes
Certain other etiologies can concentrate 
Conclusion
Extraosseous uptake of 99m Tc-MDP on skeletal scintigraphy is a common finding. We have briefly explained the various possible pathophysiological causes of extraosseous uptake. Familiarity with and increased awareness of the conditions causing extraosseous uptake will enhance the quality of interpretation of bone scintigraphy, avoid unnecessary errors in its reporting, and increase its diagnostic value. The use of hybrid SPECT-CT combines the strength of anatomical and functional imaging, both of which help in the proper anatomical localization of focal uptake, and improves the overall diagnostic accuracy of bone scintigraphy. Additionally, exclusion of disease by identification of physiological uptake and accurate identification of anatomical sites of extraosseous focus increases the specificity of bone scintigraphy, which has a direct impact on patient management. 
